ACTIV Seminar Series: Post-Acute Sequelae of SARS-CoV-2
Overview
COVID patients who experience lingering symptoms for months or weeks after initial recovery are said to have post-acute sequelae of SARS-CoV-2 (PASC), or long COVID. Major gaps in our understanding of the preclinical and clinical manifestations of PASC, however, hinder the development of effective therapeutic interventions. The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership aims to collect and disseminate research to advance efforts to treat this condition.
In this seminar series, organized by ACTIV in partnership with the National Heart, Lung, and Blood Institute (NHLBI), leading experts on PASC will present their published or ongoing research on different aspects of the disease. The sessions will be recorded and published for later use by the field.
Barriers to improving outcomes in PASC: What we do not know
Dr. Michelle Gong, MD, MS
Albert Einstein College of Medicine
Monday, October 4, 2021
10:00–11:00 am ET
COVID-19 and diabetes: A bidirectional relationship
Dr. Franck Mauvais-Jarvis, MD, PhD
Tulane School of Medicine
Thursday, October 14, 2021
10:00–11:00 am ET
Targetable plasma correlates of COVID-19 Severity: PASC relevance?
Dr. Mohamed Abdel-Mohsen, PhD
Wistar Institute
Monday, October 18, 2021
3:00–4:00 pm ET
Probing disease mechanisms of long COVID
Dr. Akiko Iwasaki, PhD
Yale University School of Medicine
Thursday, October 28, 2021
2:00–3:00 pm ET
Neurological symptoms during and after COVID-19: What can we learn from the cerebrospinal fluid?
Dr. Shelli Farhadian, MD, PhD
Yale University School of Medicine
Thursday, November 4, 2021
2:00–3:00 pm ET
PASC, COVID, and the kidney: A suPAR example
Dr. Jochen Reiser, MD, PhD
The Ralph C. Brown, MD, Professor of Internal Medicine Chairperson
Department of Internal Medicine, Rush Medical College
Friday, January 7, 2022
3:00–4:00 pm ET
Observations on long COVID through an ME/CFS lens
Peter Rowe, MD
Director, Children’s Center Chronic Fatigue Clinic, Professor of Pediatrics
Johns Hopkins Medicine
Friday, January 14, 2022
1:00–2:00 pm ET
Machine Learning Algorithm for Diagnosing Pediatric Patients with Multisystem Inflammatory Syndrome
Jane Burns, M.D., Ph.D.
Shamim Nemati, Ph.D.
University of California San Diego (UCSD) School of Medicine
Friday, January 28, 2022
11:00 am-12:00 ET
Early Risk Factors for Long COVID
Jim Heath, Ph.D.
President
Institute for Systems Biology
Wednesday, March 2, 2022
11:00 am-12:00 ET
Autoantibodies in COVID-19 and other infectious diseases
Paul J. Utz, M.D.
Professor of Medicine – Immunology & Rheumatology
Stanford University
Wednesday, March 9, 2022
2:00 pm - 3:00 EST